Literature DB >> 15024299

Canadian Cardiovascular Society classification of effort angina: an angiographic correlation.

Venkatesan Sangareddi1, Anand Chockalingam, G Gnanavelu, T Subramaniam, V Jagannathan, S Elangovan.   

Abstract

BACKGROUND: The Canadian Cardiovascular Society classification (CCSC) remains the standard for grading angina in patients with chronic stable angina. The utility value of this angina grading system in predicting the severity of coronary artery disease is not clear. AIM: We studied the relationship between the clinical angina grade and the angiographic severity of underlying coronary artery disease.
MATERIALS AND METHODS: The participants in the study were 493 patients with stable angina who had undergone coronary angiography from 1998 to 2001. They were grouped according to their anginal grading and the number of vessels diseased. Significant lesions were defined as 50% narrowing for the left main and 70% for the left and right coronaries and their major branches. STATISTICAL ANALYSIS: The chi2-test was used for statistical analysis and a P-value <0.05 was taken as significant.
RESULTS: There was no significant difference between the four angina class patients and the incidence of single-, double- and triple-vessel involvement. Class 1 patients had less left main trunk disease than class 4 patients. Class 3 and 4 patients had significantly fewer normal coronary angiograms.
CONCLUSIONS: There is generally little correlation between coronary artery disease and the CCSC of effort angina except for left main disease. Presence or absence of angina rather than the CCSC should indicate the need for coronary angiography.

Entities:  

Mesh:

Year:  2004        PMID: 15024299     DOI: 10.1097/00019501-200403000-00007

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  6 in total

1.  Two-year outcomes in patients with mild refractory angina treated with enhanced external counterpulsation.

Authors:  William E Lawson; John C K Hui; Elizabeth D Kennard; Sheryl F Kelsey; Andrew D Michaels; Ozlem Soran
Journal:  Clin Cardiol       Date:  2006-02       Impact factor: 2.882

2.  Performance of the traditional age, sex, and angina typicality-based approach for estimating pretest probability of angiographically significant coronary artery disease in patients undergoing coronary computed tomographic angiography: results from the multinational coronary CT angiography evaluation for clinical outcomes: an international multicenter registry (CONFIRM).

Authors:  Victor Y Cheng; Daniel S Berman; Alan Rozanski; Allison M Dunning; Stephan Achenbach; Mouaz Al-Mallah; Matthew J Budoff; Filippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Kavitha Chinnaiyan; Benjamin J W Chow; Augustin Delago; Millie Gomez; Martin Hadamitzky; Jörg Hausleiter; Ronald P Karlsberg; Philipp Kaufmann; Fay Y Lin; Erica Maffei; Gilbert L Raff; Todd C Villines; Leslee J Shaw; James K Min
Journal:  Circulation       Date:  2011-10-24       Impact factor: 29.690

3.  A cross-sectional study of factors predicting readmission in Thais with coronary artery disease.

Authors:  Rapin Polsook; Yupin Aungsuroch
Journal:  J Res Nurs       Date:  2020-09-16

Review 4.  Evaluating symptoms to improve quality of life in patients with chronic stable angina.

Authors:  Jeffrey W Young; Sheila Melander
Journal:  Nurs Res Pract       Date:  2013-12-23

5.  Design and Methodology of a Multicenter Randomized Clinical Trial to Evaluate the Efficacy of Tongmai Jiangtang Capsules in Type 2 Diabetic Coronary Heart Disease Patients.

Authors:  Yu Wang; Yilei Guo; Ye Lei; Shuwei Huang; Liping Dou; Chang Li; Buchang Zhao; Wei Fu; Peng Zhou; Haitong Wan; Mingjun Zhao; Jiehong Yang
Journal:  Front Pharmacol       Date:  2021-06-03       Impact factor: 5.810

6.  Acupuncture for chronic stable angina pectoris based on the theory of Meridian-Viscera Association: study protocol for a multicenter randomized controlled trial.

Authors:  Zhaoxuan He; Yi Yang; Qiao Wen; Tao Yin; Zhengjie Li; Peihong Ma; Hui Zheng; Yunhong Yang; Yongliang Jiang; Jianqiao Fang; Lei Lan; Fang Zeng
Journal:  Trials       Date:  2020-11-06       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.